Preclinical efficacy of MEK inhibition in Nras-mutant AML.
Blood
; 124(26): 3947-55, 2014 Dec 18.
Article
in En
| MEDLINE
| ID: mdl-25361812
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Monomeric GTP-Binding Proteins
/
MAP Kinase Kinase Kinases
/
Mutation
Limits:
Animals
/
Humans
Language:
En
Journal:
Blood
Year:
2014
Document type:
Article
Country of publication:
United States